收藏切换
Monitoring and analyses of adverse events following immunization in Guiyang City, 2014-2023
收藏切换
PDF
Fei CHENG1, Lan GAO1, Lian-xin TIAN2, Xue LI1, Qiu-yun WANG1
Modern Preventive Medicine | 2024, 51(12) : 2282 - 2286
Less
收藏切换
Modern Preventive Medicine | 2024, 51(12): 2282-2286
Health Supervison
Monitoring and analyses of adverse events following immunization in Guiyang City, 2014-2023
Full
Fei CHENG1, Lan GAO1, Lian-xin TIAN2, Xue LI1, Qiu-yun WANG1
Affiliations
  • Guiyang Center for Disease Prevention and Control, Guiyang, Guizhou 561000, China
Published: 2024-06-25 doi: 10.20043/j.cnki.MPM.202401463
Outline
收藏切换
Objective

To analyze the characteristics of suspected adverse events following immunization (AEFI) in Guiyang City from 2014 to 2023, to evaluate the safety of immunization in Guiyang City, and to provide guidance for improving AEFI monitoring.

Methods

Collect AEFI data and vaccine immunization data in Guiyang City from 2014 to 2023 through the “National Immunization Planning Information System” and “Guizhou Province Immunization Planning Information Management System.” Use descriptive epidemiological methods to statistically analyze the epidemiological characteristics and reported incidence rates of AEFI in Guiyang City.

Results

From 2014 to 2023, Guiyang City reported a total of 4 498 cases of AEFI, with an average annual reported incidence rate of 14.63 per 100 000. The incidence rate was the highest in 2023 (1 358 cases, 42.43/100 000) and the lowest in 2015 (23 cases, 1.85/100 000). The reported incidence rate had a statistically significant difference among different years (χ2=3 638.04,P<0.001). Yunyan District reported the most cases (1 539 cases, 25.86/100 000), while Xifeng County reported the least cases (86 cases, 6.67/100 000), and the difference among different regions was statistically significant (χ2=890.10,P<0.001). The most cases were reported in November (588 cases, 24.7/100 000) and the least in February (136 cases, 8.37/100 000), and there was a statistically significant difference among different months (χ2=277.31,P<0.001). The male-to-female ratio was 1.10:1.00, with the highest reports in the age group ≤1 year (2 697 cases, 59.96%). The outcome was recovery or improvement in 96.47% of cases.

Conclusion

2014-2023 AEFI in Guiyang is mainly a general response and the vaccination safety is good. However, the work carried out in different places varies and the monitoring sensitivity needs to be further enhanced.

Surveillance  /  Adverse events following immunization  /  Vaccine
Fei CHENG, Lan GAO, Lian-xin TIAN, Xue LI, Qiu-yun WANG. Monitoring and analyses of adverse events following immunization in Guiyang City, 2014-2023[J]. Modern Preventive Medicine, 2024 , 51 (12) : 2282 -2286 . DOI: 10.20043/j.cnki.MPM.202401463
Year 2024 volume 51 Issue 12
PDF
73
33
Cite this Article
BibTeX
Article Info
doi: 10.20043/j.cnki.MPM.202401463
  • Receive Date:2024-01-29
  • Online Date:2026-03-17
  • Published:2024-06-25
Article Data
Affiliations
History
  • Received:2024-01-29
Affiliations
    Guiyang Center for Disease Prevention and Control, Guiyang, Guizhou 561000, China
References
Share
https://castjournals.cast.org.cn/joweb/xdyfyx/EN/10.20043/j.cnki.MPM.202401463
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT